000766.SZ SHZ
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
1W: -4.7%
1M: -8.4%
3M: -17.0%
YTD: -35.4%
1Y: -32.3%
3Y: +179.7%
5Y: +211.3%
¥15.16 ($2.26)
-0.01 (-0.07%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$163M
+44.3% ▲
5Y CAGR: +16.8%
Capital Expenditures
$49M
-84.4% ▼
5Y CAGR: -4.2%
Free Cash Flow
$114M
+31.9% ▲
5Y CAGR: +52.3%
Dividends Paid
$85M
-2.0% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$107M
+257.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$361M | $35M | $30M | $43M | $56M |
| Depreciation & Amort. | $70M | $70M | $72M | $75M | $67M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $165M | -$42M | $9M | -$100M | -$51M |
| Other Non-Cash Items | $207M | $49M | $85M | $95M | $90M |
| Operating Cash Flow | $81M | $138M | $198M | $113M | $163M |
| — Investing Activities — | |||||
| Capital Expenditures | -$19M | -$25M | -$24M | -$27M | -$49M |
| Acquisitions (Net) | $2M | $17M | $2M | $0 | $0 |
| Investment Purchases | -$504M | $1M | -$6M | $0 | $0 |
| Investment Sales | $24M | $12M | $7M | $0 | $0 |
| Other Investing | -$28M | $41K | $0 | $100M | $46K |
| Investing Cash Flow | -$525M | $4M | -$21M | $73M | -$49M |
| — Financing Activities — | |||||
| Net Debt Issuance | $886M | -$257M | -$55M | -$97M | $104M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$131M | -$97M | -$89M | -$83M | -$85M |
| Other Financing | -$175M | $0 | -$490K | -$73M | -$25M |
| Financing Cash Flow | $580M | -$354M | -$144M | -$254M | -$7M |
| Net Change in Cash | $136M | -$212M | $33M | -$68M | $107M |
| Cash End of Period | $415M | $203M | $235M | $167M | $274M |
| Free Cash Flow | $62M | $113M | $174M | $86M | $114M |